On March 11, 2015, NPR All Things Considered aired a piece of news that according to a study in this week's NEJM (N Engl J Med 2015; 372:1031-1039 March 12, 2015, DOI: 10.1056/NEJMsa1409364), many scientistis failed to report results to ClinicalTrials.gov in a timely fashion during the study period, as required by FDAAA 801 (Section 801 of the Food and Drug Administration Amendments act). To listen to this piece from All Things Considered, click here.
In January 2015, the NIH Manuscript Submission (NIHMS) system will be getting a new look. To learn more about the new interface design and improvements see the NIHMS Update Announcement.
About This Guide
NIH Public Access Policy Reqirements
NIH Public Access Policy requires:
- Effective April 8, 2008, all investigators funded by the NIH must submit or have submitted for them to the NLM’s PubMed Central (PMC, NIH's free full text repository of biomedical and life sciences journal literature) an electronic version of their final, peer-reviewed manuscripts upon acceptance for publication. The final published paper must be made publicly available in PMC no later than 12 months after the official date of publication in a manner consistent with copyright law.
- As of May 25, 2008, NIH applications, proposals and progress reports must include the PubMed Central reference number (PMCID) when citing an article that falls under the policy and is authored or co-authored by the investigator, or arose from the investigator's NIH award. This policy includes applications, proposals and progress reports submitted to the NIH for the May 25, 2008 due date and subsequent due dates.
Effective July 23, 2013, PIs and PD's must use My NCBI's "My Bibliography" tool to manage their bibliographies.
Failure to comply with the NIH Public Access Policy could result in discontinuation of funding or no future funding.
Rutgers University Libraries provide support for NIH Public Access Policy and assistance to authors who have questions about the policy or need assistance in finding publisher policies, submission methods, PMCID numbers, or other information. Email to: email@example.com for additional information, questions, and support.